ID   ASCL1_HUMAN             Reviewed;         236 AA.
AC   P50553; A8K3C4; Q9BQ30;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   18-JUN-2025, entry version 211.
DE   RecName: Full=Achaete-scute homolog 1 {ECO:0000303|PubMed:8390674};
DE            Short=ASH-1 {ECO:0000303|PubMed:8390674};
DE            Short=hASH1 {ECO:0000303|PubMed:8390674};
DE   AltName: Full=Class A basic helix-loop-helix protein 46 {ECO:0000312|HGNC:HGNC:738};
DE            Short=bHLHa46 {ECO:0000312|HGNC:HGNC:738};
GN   Name=ASCL1 {ECO:0000312|HGNC:HGNC:738};
GN   Synonyms=ASH1, BHLHA46 {ECO:0000312|HGNC:HGNC:738}, HASH1
GN   {ECO:0000303|PubMed:8390674};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thyroid carcinoma;
RX   PubMed=8390674; DOI=10.1073/pnas.90.12.5648;
RA   Ball D.W., Azzoli C.G., Baylin S.B., Chi D., Dou S., Donis-Keller H.,
RA   Cumaraswamy A., Borges M., Nelkin B.D.;
RT   "Identification of a human achaete-scute homolog highly expressed in
RT   neuroendocrine tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5648-5652(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH TCF3.
RX   PubMed=10903890; DOI=10.1006/bbrc.2000.3090;
RA   Persson P., Joegi A., Grynfeld A., Paahlman S., Axelson H.;
RT   "HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a
RT   functional complex.";
RL   Biochem. Biophys. Res. Commun. 274:22-31(2000).
RN   [6]
RP   VARIANT LYS-127, AND INVOLVEMENT IN NEUROCRISTOPATHY.
RX   PubMed=38287449; DOI=10.1111/cge.14485;
RA   Malbos M., Wakeling E., Gautier T., Boespflug-Tanguy O., Busby L.,
RA   Taylor-Miller T., Dudoignon B., Bokov P., Govin J., Grisval M., Rega A.,
RA   Mourot De Rougemont M.G., Aubriot-Lorton M.H., Darmency V., Bensignor C.,
RA   Houzel A., Huet F., Denomme-Pichon A.S., Delanne J., Tran Mau-Them F.,
RA   Bruel A.L., Safraou H., Nambot S., Garde A., Philippe C., Duffourd Y.,
RA   Vitobello A., Faivre L., Thauvin-Robinet C.;
RT   "Further description of two individuals with de novo p.(Glu127Lys) missense
RT   variant in the ASCL1 gene.";
RL   Clin. Genet. 105:555-560(2024).
CC   -!- FUNCTION: Transcription factor that plays a key role in neuronal
CC       differentiation: acts as a pioneer transcription factor, accessing
CC       closed chromatin to allow other factors to bind and activate neural
CC       pathways. Directly binds the E box motif (5'-CANNTG-3') on promoters
CC       and promotes transcription of neuronal genes. The combination of three
CC       transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is sufficient to
CC       reprogram fibroblasts and other somatic cells into induced neuronal
CC       (iN) cells in vitro. Plays a role at early stages of development of
CC       specific neural lineages in most regions of the CNS, and of several
CC       lineages in the PNS. Essential for the generation of olfactory and
CC       autonomic neurons. Acts synergistically with FOXN4 to specify the
CC       identity of V2b neurons rather than V2a from bipotential p2 progenitors
CC       during spinal cord neurogenesis, probably through DLL4-NOTCH signaling
CC       activation. Involved in the regulation of neuroendocrine cell
CC       development in the glandular stomach (By similarity).
CC       {ECO:0000250|UniProtKB:Q02067}.
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another bHLH
CC       protein. Forms a heterodimer with TCF3. {ECO:0000269|PubMed:10903890}.
CC   -!- INTERACTION:
CC       P50553; O14497: ARID1A; NbExp=2; IntAct=EBI-957042, EBI-637887;
CC       P50553; Q92922: SMARCC1; NbExp=2; IntAct=EBI-957042, EBI-355653;
CC       P50553; P15923: TCF3; NbExp=4; IntAct=EBI-957042, EBI-769630;
CC       P50553; P15884: TCF4; NbExp=8; IntAct=EBI-957042, EBI-533224;
CC       P50553; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-957042, EBI-741480;
CC       P50553; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-957042, EBI-947187;
CC       P50553; Q9Y2K6: USP20; NbExp=3; IntAct=EBI-957042, EBI-2511991;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q02067}.
CC   -!- DISEASE: Note=Genetic variations in ASCL1 may play a role in disorders
CC       of the neurocristopathy spectrum manifesting with features of
CC       Hirschsprung disease, congenital central hypoventilation syndrome,
CC       dysautonomia, in addition to neurodevelopmental issues.
CC       {ECO:0000269|PubMed:38287449}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/713/ASCL1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L08424; AAA58376.1; -; mRNA.
DR   EMBL; AK290539; BAF83228.1; -; mRNA.
DR   EMBL; CH471054; EAW97703.1; -; Genomic_DNA.
DR   EMBL; BC001638; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC002341; AAH02341.1; -; mRNA.
DR   EMBL; BC003134; AAH03134.1; -; mRNA.
DR   EMBL; BC004425; AAH04425.1; -; mRNA.
DR   EMBL; BC031299; AAH31299.1; -; mRNA.
DR   CCDS; CCDS31886.1; -.
DR   PIR; A48279; A48279.
DR   RefSeq; NP_004307.2; NM_004316.4.
DR   AlphaFoldDB; P50553; -.
DR   SMR; P50553; -.
DR   BioGRID; 106921; 39.
DR   FunCoup; P50553; 665.
DR   IntAct; P50553; 33.
DR   STRING; 9606.ENSP00000266744; -.
DR   iPTMnet; P50553; -.
DR   PhosphoSitePlus; P50553; -.
DR   BioMuta; ASCL1; -.
DR   DMDM; 20455478; -.
DR   MassIVE; P50553; -.
DR   PaxDb; 9606-ENSP00000266744; -.
DR   PeptideAtlas; P50553; -.
DR   Antibodypedia; 18050; 542 antibodies from 42 providers.
DR   DNASU; 429; -.
DR   Ensembl; ENST00000266744.4; ENSP00000266744.3; ENSG00000139352.4.
DR   GeneID; 429; -.
DR   KEGG; hsa:429; -.
DR   MANE-Select; ENST00000266744.4; ENSP00000266744.3; NM_004316.4; NP_004307.2.
DR   UCSC; uc001tjr.5; human.
DR   AGR; HGNC:738; -.
DR   CTD; 429; -.
DR   DisGeNET; 429; -.
DR   GeneCards; ASCL1; -.
DR   HGNC; HGNC:738; ASCL1.
DR   HPA; ENSG00000139352; Tissue enhanced (brain, liver, pituitary gland).
DR   MalaCards; ASCL1; -.
DR   MIM; 100790; gene.
DR   OpenTargets; ENSG00000139352; -.
DR   Orphanet; 99803; Haddad syndrome.
DR   VEuPathDB; HostDB:ENSG00000139352; -.
DR   eggNOG; KOG4029; Eukaryota.
DR   GeneTree; ENSGT00940000162483; -.
DR   HOGENOM; CLU_063523_3_0_1; -.
DR   InParanoid; P50553; -.
DR   OMA; QPAACFF; -.
DR   OrthoDB; 5976910at2759; -.
DR   PAN-GO; P50553; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; P50553; -.
DR   PathwayCommons; P50553; -.
DR   Reactome; R-HSA-9031628; NGF-stimulated transcription.
DR   SignaLink; P50553; -.
DR   SIGNOR; P50553; -.
DR   BioGRID-ORCS; 429; 28 hits in 1180 CRISPR screens.
DR   GeneWiki; ASCL1; -.
DR   GenomeRNAi; 429; -.
DR   Pharos; P50553; Tbio.
DR   PRO; PR:P50553; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P50553; protein.
DR   Bgee; ENSG00000139352; Expressed in ganglionic eminence and 116 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IBA:GO_Central.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0070888; F:E-box binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0003676; F:nucleic acid binding; EXP:DisProt.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0061104; P:adrenal chromaffin cell differentiation; IEA:Ensembl.
DR   GO; GO:0061103; P:carotid body glomus cell differentiation; IEA:Ensembl.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0071259; P:cellular response to magnetism; IEA:Ensembl.
DR   GO; GO:0021954; P:central nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0021892; P:cerebral cortex GABAergic interneuron differentiation; IEP:UniProtKB.
DR   GO; GO:0021902; P:commitment of neuronal cell to specific neuron type in forebrain; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; NAS:UniProtKB.
DR   GO; GO:0061100; P:lung neuroendocrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0097475; P:motor neuron migration; IEA:Ensembl.
DR   GO; GO:0050883; P:musculoskeletal movement, spinal reflex action; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0007400; P:neuroblast fate determination; IEA:Ensembl.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0022008; P:neurogenesis; IDA:UniProtKB.
DR   GO; GO:0048666; P:neuron development; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0048663; P:neuron fate commitment; ISS:UniProtKB.
DR   GO; GO:0048665; P:neuron fate specification; ISS:UniProtKB.
DR   GO; GO:0003358; P:noradrenergic neuron development; ISS:UniProtKB.
DR   GO; GO:0003359; P:noradrenergic neuron fate commitment; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060166; P:olfactory pit development; IEA:Ensembl.
DR   GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030856; P:regulation of epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0050767; P:regulation of neurogenesis; IBA:GO_Central.
DR   GO; GO:0060165; P:regulation of timing of subpallium neuron differentiation; IEA:Ensembl.
DR   GO; GO:0070849; P:response to epidermal growth factor; IEA:Ensembl.
DR   GO; GO:0051593; P:response to folic acid; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:UniProtKB.
DR   GO; GO:0007423; P:sensory organ development; IBA:GO_Central.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl.
DR   GO; GO:0061102; P:stomach neuroendocrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0060163; P:subpallium neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB.
DR   GO; GO:0048485; P:sympathetic nervous system development; NAS:UniProtKB.
DR   GO; GO:0060579; P:ventral spinal cord interneuron fate commitment; ISS:UniProtKB.
DR   GO; GO:0021750; P:vestibular nucleus development; IEA:Ensembl.
DR   CDD; cd19742; bHLH_TS_ASCL1_Mash1; 1.
DR   DisProt; DP01942; -.
DR   FunFam; 4.10.280.10:FF:000029; Achaete-scute family bHLH transcription factor 1; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR015660; MASH1/Ascl1a-like.
DR   PANTHER; PTHR13935:SF66; ACHAETE-SCUTE HOMOLOG 1; 1.
DR   PANTHER; PTHR13935; ACHAETE-SCUTE TRANSCRIPTION FACTOR-RELATED; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   neXtProt; NX_P50553; -.
DR   PharmGKB; PA26416; -.
DR   TreeFam; TF322889; -.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Developmental protein; Differentiation;
KW   Disease variant; DNA-binding; Neurogenesis; Nucleus;
KW   Proteomics identification; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..236
FT                   /note="Achaete-scute homolog 1"
FT                   /id="PRO_0000127126"
FT   DOMAIN          118..170
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          42..98
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        17..26
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        42..70
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..90
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         156
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02067"
FT   VARIANT         127
FT                   /note="E -> K (found in two unrelated individuals with
FT                   short-segment Hirschsprung disease, dysautonomia, increased
FT                   lower limb reflexes and neurodevelopmental issues; likely
FT                   pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:38287449"
FT                   /id="VAR_089665"
FT   VARIANT         158
FT                   /note="E -> G (in dbSNP:rs1803157)"
FT                   /id="VAR_013179"
FT   CONFLICT        62
FT                   /note="Q -> QQQ (in Ref. 1; AAA58376)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   236 AA;  25454 MW;  A7D784329305B49A CRC64;
     MESSAKMESG GAGQQPQPQP QQPFLPPAAC FFATAAAAAA AAAAAAAQSA QQQQQQQQQQ
     QQAPQLRPAA DGQPSGGGHK SAPKQVKRQR SSSPELMRCK RRLNFSGFGY SLPQQQPAAV
     ARRNERERNR VKLVNLGFAT LREHVPNGAA NKKMSKVETL RSAVEYIRAL QQLLDEHDAV
     SAAFQAGVLS PTISPNYSND LNSMAGSPVS SYSSDEGSYD PLSPEEQELL DFTNWF
//
